In December of 2008, CB Fleet Company, Inc. recalled their over-the-counter colonoscopy preparation drug Fleet Phospho-soda after warnings from the Food and Drug Administration (FDA) and several reported cases of patients developing a kidney problem called acute phosphate nephropathy. In acute phosphate nephropathy, calcium-phosphate crystals deposit in the renal tubules, causing permanent kidney damage that can result in the need for life-long dialysis.
Immediately after the FDA warning, C.B. Fleet Company announced a recall of their OTC products Fleet Phospho-soda® and EZ-Prep Bowel Cleansing System®. Fleet Phosphasoda contains oral sodium phosphate, which was approved by the FDA for OTC use as a laxative.
However, Fleet promoted their laxative for use at very high doses as a bowel prep without adequate warnings about the potential risk for kidney damage for years prior to the recall. Some patients, especially those with known kidney disorders, may have been able to avoid potentially life-threatening acute phosphate nephropathy if proper warnings had been provided.
If you have taken OTC Phosphosoda in preparation for a colonoscopy, radiological procedure or surgery, and have developed kidney problems, contact your doctor immediately to discuss a possible link.
If you used a Fleet Phospho-soda or EZ-Prep Bowel Cleansing System product and have been hurt or injured, you might be entitled to compensation. Please contact the pharmaceutical lawyers at Carr & Carr Attorneys for a free evaluation. Carr and Carr Attorneys has represented thousands of people across Oklahoma, Arkansas and the rest of the country for over the past 35 years.
Posted by Michael